Featured Products

My Quote Request

No products added yet

6505-01-080-9414

20 Products

HEAD & SHOULDERS

PYRITHIONE ZINC SHAMPOO

NSN, MFG P/N

6505010809414

NSN

6505-01-080-9414

View More Info

HEAD & SHOULDERS

PYRITHIONE ZINC SHAMPOO

NSN, MFG P/N

6505010809414

NSN

6505-01-080-9414

MFG

PROCTER & GAMBLE DISTRIBUTING COMPANY THE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE,W/W PYRITHIONE ZINC ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE

NDC62794-0002-51

TRYPSIN,BALSAM PERU,AND CASTOR OIL SOLUTION

NSN, MFG P/N

6505010802380

NSN

6505-01-080-2380

View More Info

NDC62794-0002-51

TRYPSIN,BALSAM PERU,AND CASTOR OIL SOLUTION

NSN, MFG P/N

6505010802380

NSN

6505-01-080-2380

MFG

MYLAN BERTEK PHARMACEUTICALS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: EACH 0.820 MILLILITER CONTAINS 72.500 MILLIGRAMS BALSAM PERU ACTIVE INGREDIENT AND 650.000 MILLIGRAMS CASTOR OIL ACTIVE INGREDIENT AND 0.100 MILLIGRAMS TRYPSIN ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRYPSIN BALSAM PERU AND CASTOR OIL SOLUTION AEROSOL CAN 4OZ
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HICKAM
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: CAN, AEROSOL

56H4

ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION

NSN, MFG P/N

6505010802381

NSN

6505-01-080-2381

View More Info

56H4

ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION

NSN, MFG P/N

6505010802381

NSN

6505-01-080-2381

MFG

WAMPOLE LABORATORIES DIV OF CARTER-WALLACE INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V HYDROCORTISONE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, V/V ACETIC ACID, GLACIAL ACTIVE INGREDIENT AND 0.020 PERCENTAGE, W/V BENZETHONIUM CHLORIDE ACTIVE INGREDIENT AND 0.015 PERCENTAGE, W/V SODIUM ACETATE ACTIVE INGREDIENT AND 0.200
ADMINISTRATION: OTIC
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC
~1: PERCENTAGE, W/V CITRIC ACID ACTIVE INGREDIENT AND 3.000 PERCENTAGE; V/V PROPYLENE GLYCOL DIACETATE ACTIVE INGREDIENT

NDC0037-3811-12

ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION

NSN, MFG P/N

6505010802381

NSN

6505-01-080-2381

View More Info

NDC0037-3811-12

ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION

NSN, MFG P/N

6505010802381

NSN

6505-01-080-2381

MFG

WAMPOLE LABORATORIES DIV OF CARTER-WALLACE INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V HYDROCORTISONE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, V/V ACETIC ACID, GLACIAL ACTIVE INGREDIENT AND 0.020 PERCENTAGE, W/V BENZETHONIUM CHLORIDE ACTIVE INGREDIENT AND 0.015 PERCENTAGE, W/V SODIUM ACETATE ACTIVE INGREDIENT AND 0.200
ADMINISTRATION: OTIC
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC
~1: PERCENTAGE, W/V CITRIC ACID ACTIVE INGREDIENT AND 3.000 PERCENTAGE; V/V PROPYLENE GLYCOL DIACETATE ACTIVE INGREDIENT

VOSOL HC OTIC

ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION

NSN, MFG P/N

6505010802381

NSN

6505-01-080-2381

View More Info

VOSOL HC OTIC

ACETIC ACID,GLACIAL,BENZETHONIUM CHLORIDE,HYDROCORTISONE,PROPYLENE GLYCOL,PROPYLENE GLYCOL DIACETATE,AND SODIUM ACETATE SOLUTION

NSN, MFG P/N

6505010802381

NSN

6505-01-080-2381

MFG

WAMPOLE LABORATORIES DIV OF CARTER-WALLACE INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V HYDROCORTISONE ACTIVE INGREDIENT AND 2.000 PERCENTAGE, V/V ACETIC ACID, GLACIAL ACTIVE INGREDIENT AND 0.020 PERCENTAGE, W/V BENZETHONIUM CHLORIDE ACTIVE INGREDIENT AND 0.015 PERCENTAGE, W/V SODIUM ACETATE ACTIVE INGREDIENT AND 0.200
ADMINISTRATION: OTIC
PHARMACEUTICAL VEHICLE TYPE: PROPYLENE GLYCOL
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC
~1: PERCENTAGE, W/V CITRIC ACID ACTIVE INGREDIENT AND 3.000 PERCENTAGE; V/V PROPYLENE GLYCOL DIACETATE ACTIVE INGREDIENT

NDC00091-0690-10

HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE TOPICAL FOAM

NSN, MFG P/N

6505010802904

NSN

6505-01-080-2904

View More Info

NDC00091-0690-10

HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE TOPICAL FOAM

NSN, MFG P/N

6505010802904

NSN

6505-01-080-2904

MFG

AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V HYDROCORTISONE ACETATE ACTIVE INGREDIENT AND 1.000 PERCENTAGE, W/V PRAMOXINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: RECTAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE FOAM 10GM
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 GRAMS
PRIMARY CONTAINER TYPE: CAN, AEROSOL
SPECIAL FEATURES: W/APPLICATOR

NDC00536-2145-19

HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE TOPICAL FOAM

NSN, MFG P/N

6505010802904

NSN

6505-01-080-2904

View More Info

NDC00536-2145-19

HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE TOPICAL FOAM

NSN, MFG P/N

6505010802904

NSN

6505-01-080-2904

MFG

RUGBY GROUP INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V HYDROCORTISONE ACETATE ACTIVE INGREDIENT AND 1.000 PERCENTAGE, W/V PRAMOXINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: RECTAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE FOAM 10GM
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 GRAMS
PRIMARY CONTAINER TYPE: CAN, AEROSOL
SPECIAL FEATURES: W/APPLICATOR

NDC00574-0002-11

ASPIRIN DELAYED-RELEASE TABLETS,USP

NSN, MFG P/N

6505010804111

NSN

6505-01-080-4111

View More Info

NDC00574-0002-11

ASPIRIN DELAYED-RELEASE TABLETS,USP

NSN, MFG P/N

6505010804111

NSN

6505-01-080-4111

MFG

PADDOCK LABORATORIES INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ASPIRIN DELAYED RELEASE TABLETS USP 325MG STRIP I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 PER PACKAGE

NDC51079-0018-20

ASPIRIN DELAYED-RELEASE TABLETS,USP

NSN, MFG P/N

6505010804111

NSN

6505-01-080-4111

View More Info

NDC51079-0018-20

ASPIRIN DELAYED-RELEASE TABLETS,USP

NSN, MFG P/N

6505010804111

NSN

6505-01-080-4111

MFG

UDL LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
COATING FEATURE: FILM, ENTERIC
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ASPIRIN DELAYED RELEASE TABLETS USP 325MG STRIP I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 PER PACKAGE

8650

DEXTROSE INJECTION,USP

NSN, MFG P/N

6505010805964

NSN

6505-01-080-5964

View More Info

8650

DEXTROSE INJECTION,USP

NSN, MFG P/N

6505010805964

NSN

6505-01-080-5964

MFG

INVENEX LABORATORIES LIFE TECHNOLOGIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS INFUSION
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SINGLE DOSE VIAL

NDC0467-0086-25

DEXTROSE INJECTION,USP

NSN, MFG P/N

6505010805964

NSN

6505-01-080-5964

View More Info

NDC0467-0086-25

DEXTROSE INJECTION,USP

NSN, MFG P/N

6505010805964

NSN

6505-01-080-5964

MFG

INVENEX LABORATORIES LIFE TECHNOLOGIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS INFUSION
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SINGLE DOSE VIAL

2B2584

DEXTROSE AND ELECTROLYTE INJECTION

NSN, MFG P/N

6505010805966

NSN

6505-01-080-5966

View More Info

2B2584

DEXTROSE AND ELECTROLYTE INJECTION

NSN, MFG P/N

6505010805966

NSN

6505-01-080-5966

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 98.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 50.000 GRAMS DEXTROSE PER LITER AND 140.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 27 MEQ. ACETATE ION PER LITER AND 23 MEQ. GLUCONATE ION PER LITER AND 3 MEQ. MAGNESIUM ION PER LITER AND 5 MEQ.
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
~1: POTASSIUM ION PER LITER

NDC00074-7968-09

DEXTROSE AND ELECTROLYTE INJECTION

NSN, MFG P/N

6505010805966

NSN

6505-01-080-5966

View More Info

NDC00074-7968-09

DEXTROSE AND ELECTROLYTE INJECTION

NSN, MFG P/N

6505010805966

NSN

6505-01-080-5966

MFG

ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 98.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 50.000 GRAMS DEXTROSE PER LITER AND 140.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 27 MEQ. ACETATE ION PER LITER AND 23 MEQ. GLUCONATE ION PER LITER AND 3 MEQ. MAGNESIUM ION PER LITER AND 5 MEQ.
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
~1: POTASSIUM ION PER LITER

NDC00338-0149-04

DEXTROSE AND ELECTROLYTE INJECTION

NSN, MFG P/N

6505010805966

NSN

6505-01-080-5966

View More Info

NDC00338-0149-04

DEXTROSE AND ELECTROLYTE INJECTION

NSN, MFG P/N

6505010805966

NSN

6505-01-080-5966

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 98.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 50.000 GRAMS DEXTROSE PER LITER AND 140.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 27 MEQ. ACETATE ION PER LITER AND 23 MEQ. GLUCONATE ION PER LITER AND 3 MEQ. MAGNESIUM ION PER LITER AND 5 MEQ.
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
~1: POTASSIUM ION PER LITER

NORMOSOL-R LIFE CARE

DEXTROSE AND ELECTROLYTE INJECTION

NSN, MFG P/N

6505010805966

NSN

6505-01-080-5966

View More Info

NORMOSOL-R LIFE CARE

DEXTROSE AND ELECTROLYTE INJECTION

NSN, MFG P/N

6505010805966

NSN

6505-01-080-5966

MFG

ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 98.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 50.000 GRAMS DEXTROSE PER LITER AND 140.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 27 MEQ. ACETATE ION PER LITER AND 23 MEQ. GLUCONATE ION PER LITER AND 3 MEQ. MAGNESIUM ION PER LITER AND 5 MEQ.
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
~1: POTASSIUM ION PER LITER

PLASMA-LYTE 148 VIAFLEX

DEXTROSE AND ELECTROLYTE INJECTION

NSN, MFG P/N

6505010805966

NSN

6505-01-080-5966

View More Info

PLASMA-LYTE 148 VIAFLEX

DEXTROSE AND ELECTROLYTE INJECTION

NSN, MFG P/N

6505010805966

NSN

6505-01-080-5966

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 98.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 50.000 GRAMS DEXTROSE PER LITER AND 140.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 27 MEQ. ACETATE ION PER LITER AND 23 MEQ. GLUCONATE ION PER LITER AND 3 MEQ. MAGNESIUM ION PER LITER AND 5 MEQ.
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 12
~1: POTASSIUM ION PER LITER

6365-02

ERYTHROMYCIN LACTOBIONATE FOR INJECTION,USP

NSN, MFG P/N

6505010809409

NSN

6505-01-080-9409

View More Info

6365-02

ERYTHROMYCIN LACTOBIONATE FOR INJECTION,USP

NSN, MFG P/N

6505010809409

NSN

6505-01-080-9409

MFG

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV

Description

ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHYSICAL FORM: CRYSTAL OR POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ALSO CONTAINS 90 MG. BENZYL ALCOHOL AS PRESERVATIVE; IN 20 ML. VIAL

ERYTHROCIN

ERYTHROMYCIN LACTOBIONATE FOR INJECTION,USP

NSN, MFG P/N

6505010809409

NSN

6505-01-080-9409

View More Info

ERYTHROCIN

ERYTHROMYCIN LACTOBIONATE FOR INJECTION,USP

NSN, MFG P/N

6505010809409

NSN

6505-01-080-9409

MFG

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV

Description

ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHYSICAL FORM: CRYSTAL OR POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ALSO CONTAINS 90 MG. BENZYL ALCOHOL AS PRESERVATIVE; IN 20 ML. VIAL

NDC00074-6365-02

ERYTHROMYCIN LACTOBIONATE FOR INJECTION,USP

NSN, MFG P/N

6505010809409

NSN

6505-01-080-9409

View More Info

NDC00074-6365-02

ERYTHROMYCIN LACTOBIONATE FOR INJECTION,USP

NSN, MFG P/N

6505010809409

NSN

6505-01-080-9409

MFG

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV

Description

ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHYSICAL FORM: CRYSTAL OR POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ALSO CONTAINS 90 MG. BENZYL ALCOHOL AS PRESERVATIVE; IN 20 ML. VIAL

00025

PYRITHIONE ZINC SHAMPOO

NSN, MFG P/N

6505010809414

NSN

6505-01-080-9414

View More Info

00025

PYRITHIONE ZINC SHAMPOO

NSN, MFG P/N

6505010809414

NSN

6505-01-080-9414

MFG

PROCTER & GAMBLE DISTRIBUTING COMPANY THE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE,W/W PYRITHIONE ZINC ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE